Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Postprandial Glucose and Insulin Responses.
Status: Enrolling
Updated:  12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Postprandial Glucose and Insulin Responses.
Status: Enrolling
Updated: 12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Postprandial Glucose and Insulin Responses.
Status: Enrolling
Updated:  12/31/1969
Great Lakes Clinical Trials
mi
from
Chicago, IL
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Glucose and Insulin Responses
A Randomized, Crossover Study to Assess the Effects of Dietary Fiber-containing Bars on Postprandial Glucose and Insulin Responses.
Status: Enrolling
Updated: 12/31/1969
Great Lakes Clinical Trials
mi
from
Chicago, IL
Click here to add this to my saved trials
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated:  12/31/1969
NW Pituitary Center and Neurological Surgery
mi
from
Portland, OR
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated: 12/31/1969
NW Pituitary Center and Neurological Surgery
mi
from
Portland, OR
Click here to add this to my saved trials
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Federal University of Minas Gerais
mi
from
Belo Horizonte,
SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Testing the Use of SAGIT for Classification of Patients With Acromegaly in Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Federal University of Minas Gerais
mi
from
Belo Horizonte,
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Baptist Health System, Inc.
mi
from
Birmingham, AL
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Baptist Health System, Inc.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Pituitary Center
mi
from
Los Angeles, CA
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Pituitary Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Northwestern Medical Facility
mi
from
Chicago, IL
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Northwestern Medical Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
Ben Taub Hospital
mi
from
Houston, TX
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
Ben Taub Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated:  12/31/1969
St Ann's Faculty Hospital
mi
from
Brno,
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
Phase II, Multicentre, Randomized, Double-blind Study in Acromegalic Patients Evaluating the Efficacy and Safety of a Single Deep Subcutaneous Administration of Lanreotide Autogel (60, 90 or 120mg) Versus Placebo Followed by a Single Blind Fixed Dose Phase Evaluating the Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Profile of Multiple Deep Subcutaneous Administrations of Lanreotide Autogel (60, 90 & 120mg) Ending in Open Label Dose Titration Phase.
Status: Enrolling
Updated: 12/31/1969
St Ann's Faculty Hospital
mi
from
Brno,
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Diabetes And Endocrine Associates
mi
from
La Mesa, CA
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Diabetes And Endocrine Associates
mi
from
La Mesa, CA
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Denver VA Medical Center
mi
from
Denver, CO
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Massachussetts General Hospital
mi
from
Boston, MA
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Massachussetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
NYU School of Medicine
mi
from
New York, NY
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Sisters of Charity Hospital, Buffalo
mi
from
Williamsville, NY
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Sisters of Charity Hospital, Buffalo
mi
from
Williamsville, NY
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Research Institute of Dallas
mi
from
Dallas, TX
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Research Institute of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Screening of Lysosomal Storage Disorders Diseases in Minority Groups
Enzymatic and Genotypic Screening of Lysosomal Storage Diseases in Minority Groups
Status: Enrolling
Updated:  12/31/1969
LDRTC
mi
from
Fairfax, VA
Screening of Lysosomal Storage Disorders Diseases in Minority Groups
Enzymatic and Genotypic Screening of Lysosomal Storage Diseases in Minority Groups
Status: Enrolling
Updated: 12/31/1969
LDRTC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Effect of Dietary Macronutrient Composition
Effect of Dietary Macronutrient Composition on Liver Substrate Metabolism
Status: Enrolling
Updated:  12/31/1969
Center for Human Nutrition
mi
from
Dallas, TX
Effect of Dietary Macronutrient Composition
Effect of Dietary Macronutrient Composition on Liver Substrate Metabolism
Status: Enrolling
Updated: 12/31/1969
Center for Human Nutrition
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Alabama Therapeutics CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Usc Crs
mi
from
Los Angeles, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Usc Crs
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Stanford CRS
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Ucsd, Avrc Crs
mi
from
San Diego, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Ucsd, Avrc Crs
mi
from
San Diego, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
The Ponce de Leon Ctr. CRS
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Univ. of Hawaii at Manoa, Leahi Hosp.
mi
from
Honolulu, HI
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Rush Univ. Med. Ctr. ACTG CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Indiana Univ. School of Medicine, Infectious Disease Research Clinic
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
University of Minnesota, ACTU
mi
from
Minneapolis, MN
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
University of Minnesota, ACTU
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Beth Israel Med. Ctr. ACTU
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Cornell CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Cornell CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
HIV Prevention & Treatment CRS
mi
from
New York, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
HIV Prevention & Treatment CRS
mi
from
New York, NY
Click here to add this to my saved trials
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated:  12/31/1969
Trillium Health ACTG CRS
mi
from
Rochester, NY
Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy
A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy
Status: Enrolling
Updated: 12/31/1969
Trillium Health ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials